𝔖 Bobbio Scriptorium

✦ LIBER ✦

P.2.b.027 A phase II randomized, double-blind, placebo-controlled trial of GLYX-13 for the rapid treatment of major depressive disorder (MDD) using central ratings

✍ Scribed by Popp, D.; Burch, R.; Williams, J.B.W.; Price, L.M.; Detke, M.J.

Book ID: 123033516
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 73 KB
Volume: 23
Category: Article
ISSN: 0924-977X
DOI: 10.1016/S0924-977X(13)70526-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2210 – A phase II randomized, double-bli

2210 – A phase II randomized, double-blind, placebo-controlled trial of GLYX-13 for the rapid treatment of major depressive disorder using central ratings

✍ Popp, D.; Burch, R.; Williams, J.B.W.; Price, L.M.; Detke, M.J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 32 KB

[American Thoracic Society American Thor

[American Thoracic Society American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California - ()] A101. PHARMACOLOGICAL TREATMENT OF COPD: OLD AND NEW - Pearl Therapeutics' Combination LAMA/LABA MDI (GFF-MDI, PT003) Provides A Significant Benefit On Home Peak Expiratory Flow Rate (PEFR) And Reduces The Need For Rescue Albuterol Use Compared To Its Components Administered Alone, Spiriva® Handihaler®, And Foradil® Aerolizer® In A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study In Patients With COPD

✍ Reisner, Colin; Rennard, Stephen I.; Fogarty, Charles; Fischer, Tracy; Rose, Ear 📂 Article 📅 2012 🏛 American Thoracic Society ⚖ 20 KB